Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma—Who Will Benefit from a Secondary Resection?

Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma—Who Will Benefit from a Secondary Resection?

<i>Background and Objectives:</i> An increasing number of patients (pts) with locally advanced pancreatic cancer (LAPC) are treated with an intensive neoadjuvant therapy to obtain a secondary curative resection. Only a certain number of patients benefit from this intention. The aim of th...

Full description

Bibliographic Details
Main Authors: Nathalie Rosumeck, Lea Timmermann, Fritz Klein, Marcus Bahra, Sebastian Stintzig, Thomas Malinka, Uwe Pelzer
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Medicina
Subjects:
pancreatic cancer
neoadjuvant therapy
induction therapy
secondary resection
pancreatic surgery
Online Access:https://www.mdpi.com/1010-660X/57/1/77

Similar Items

Similar Items